Patients with BCharboring the PALB2 mutation appear to be more likely to presentthe triple-negative phenotype, advanced disease stage, and higher Ki-67 levels thanpatients with other familial or sporadic BC (30). The gene discussed is MKI67; the disease is breast cancer.